[144] Legend Biotech Corp SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Legend Biotech Corp (LEGN) reports a proposed sale of 307 American Depositary Shares (ADSs) with an aggregate market value of $10,438 and approximately 367,298,315 ADSs outstanding. The securities were acquired on 09/20/2025 through restricted stock vesting from the issuer and the stated nature of payment is compensation. The approximate date of sale listed is 09/23/2025. The filer also disclosed a prior sale on 06/24/2025 of 307 ADSs by Corazon D. Sanders for gross proceeds of $10,551.59. Several standard filing fields (issuer name, filer CIK/CCC, and contact details) appear blank in the provided content.

Insights

Securities Analyst

TL;DR: Small, routine Rule 144 sale of vested ADSs; immaterial to company capitalization.

The filing documents a proposed Rule 144 sale of 307 ADSs acquired by restricted stock vesting on 09/20/2025 with an approximate sale date of 09/23/2025 and aggregate market value of $10,438. Given the company's reported ADS outstanding base of 367,298,315, this quantity represents an immaterial fraction of shares outstanding. The transaction appears compensatory rather than market-driven, and a similar 307-ADS sale on 06/24/2025 generated $10,551.59, consistent with small, routine insider selling. Absent additional context (issuer identity in the filing, role of the seller), there is no evident material impact on valuation or liquidity.

Corporate Governance Expert

TL;DR: Routine insider vesting and sale; disclosure is standard but missing some administrative fields.

The notice indicates restricted stock vesting and planned sale under Rule 144, a common mechanism for insiders to sell vested equity. The filer representation about no undisclosed material adverse information is included, as required. However, the filing text omits several administrative identifiers (issuer name, filer CIK/CCC, contact details), which are important for transparency and electronic processing. From a governance perspective, the substance—small compensatory sale—is routine and not a red flag, but complete administrative disclosures should be present for clarity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	307	10438.00	367298315	09/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
American Depositary Shares	09/20/2025	Restricted Stock Vesting	Issuer			307	09/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Corazon D. Sanders 2101 Cottontail Lane Somerset NJ 08873	American Depositary Shares	06/24/2025	307	10551.59

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the LEGN Form 144 report?

The filing reports a proposed sale of 307 American Depositary Shares (ADSs) with aggregate market value of $10,438, acquired via restricted stock vesting on 09/20/2025.

When is the approximate sale date listed on the Form 144?

The filing lists an approximate date of sale of 09/23/2025.

How many ADSs does the company have outstanding according to the filing?

The Form 144 shows 367,298,315 shares or ADSs outstanding.

Was there any prior sale by the same person in the past three months?

Yes. The filing discloses a sale on 06/24/2025 of 307 ADSs by Corazon D. Sanders for gross proceeds of $10,551.59.

How were the securities acquired according to the filing?

The securities were acquired on 09/20/2025 by restricted stock vesting from the issuer, with the nature of payment listed as compensation.

Are there any missing administrative details in this Form 144?

Yes. The provided content omits the issuer name, filer CIK/CCC, and submission contact details in the visible fields.